Development of a photo-crosslinkable diaminoquinazoline inhibitor for target identification in plasmodium falciparum
File(s)ACS paper_final_revised_clean.docx (3.98 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Diaminoquinazolines represent a privileged scaffold for antimalarial discovery, including use as putative Plasmodium histone lysine methyltransferase inhibitors. Despite this, robust evidence for their molecular targets is lacking. Here we report the design and development of a small-molecule photo-crosslinkable probe to investigate the targets of our diaminoquinazoline series. We demonstrate the effectiveness of our designed probe for photoaffinity labelling of Plasmodium lysates and identify similarities between the target profiles of the probe and the representative diaminoquinazoline BIX-01294. Initial pull-down proteomics experiments identified 104 proteins from different classes, many of which are essential, highlighting the suitability of the developed probe as a valuable tool for target identification in Plasmodium falciparum.
Date Issued
2018-01-29
Date Acceptance
2018-01-29
Citation
ACS Infectious Diseases, 2018, 4 (4), pp.523-530
ISSN
2373-8227
Publisher
American Chemical Society
Start Page
523
End Page
530
Journal / Book Title
ACS Infectious Diseases
Volume
4
Issue
4
Copyright Statement
Copyright © 2018 American Chemical Society
Sponsor
Wellcome Trust
Wellcome Trust
Grant Number
100993/Z/13/Z
100993/Z/13/Z
Subjects
Science & Technology
Life Sciences & Biomedicine
Chemistry, Medicinal
Infectious Diseases
Pharmacology & Pharmacy
malaria
proteomics
photoaffinity probe
pull-down
BIX-01294
HISTONE METHYLTRANSFERASE INHIBITORS
ANTIMALARIAL ACTIVITY
CHEMICAL PROBE
GENE-FUNCTION
MALARIA
STAGE
G9A
QUINAZOLINES
PANTHER
GLP
Publication Status
Published